Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Schmidt, M
Pathologie, Prognose und PrädiktionUntch / Harbeck / Thomssen (Hrsg). Colloquium Senologie 2021 / 2022. München: Agileum 2021
Krajnak, Slavomir; Decker, Thomas; Schollenberger, Lukas et al.
Phase II study of metronomic treatment with daily oral vinorelbine as first-line chemotherapy in patients with advanced/metastatic HR+/HER2-breast cancer resistant to endocrine therapy: VinoMetro-AGO-B-046JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. Bd. 147. H. 11. 2021 S. 3391-3400
Marme, Frederik; Stickeler, Elmar; Furlanetto, Jenny et al.
Phase III postneoadjuvant study evaluating sacituzumab govitecan, an antibody drug conjugate in primary HER2-negative breast cancer patients with high relapse risk after standard neoadjuvant treatment: SASCIA.JOURNAL OF CLINICAL ONCOLOGY. Bd. 39. H. 15. 2021
Moebus, Volker; Lueck, Hans-Joachim; Ladda, Ekkehart et al.
Phase III randomised trial comparing intense dose-dense chemotherapy to tailored dose-dense chemotherapy in high-risk early breast cancer (GAIN-2)EUROPEAN JOURNAL OF CANCER. Bd. 156. 2021 S. 138-148
Riecke, Kerstin; Mueller, Volkmar; Weide, Rudolf et al.
Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry-Comparison of Three Different GPA Prognostic ScoresCANCERS. Bd. 13. H. 4. 2021
Glasbey, James C.; Omar, Omar; Nepogodiev, Dmitri et al.
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemicBRITISH JOURNAL OF SURGERY. Bd. 108. H. 1. 2021 S. 88-96
Schmidt, Marcus; Edlund, Karolina; Hengstler, Jan G. et al.
Prognostic Impact of Immunoglobulin Kappa C (IGKC) in Early Breast CancerCANCERS. Bd. 13. H. 14. 2021
Harter, P.; Sehouli, J.; Vergote, I et al.
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian CancerNEW ENGLAND JOURNAL OF MEDICINE. Bd. 385. H. 23. 2021 S. 2123-2131
Wockel, Achim; Brucker, Cosima; Decker, Thomas et al.
Real-world efficacy of ribociclib plus aromatase inhibitor/fulvestrant, or endocrine monotherapy, or chemotherapy as first-line treatment in women with HR-positive, HER2-negative locally advanced or metastatic breast cancer: Third interim analysis from the RIBANNA studyCANCER RESEARCH. Bd. 81. H. 4. 2021
Krajnak, Slavomir; Jakel, Jorg; Anic, Katharina et al.
Role of integrins in the metastatic spread of high-grade serous ovarian cancerARCHIVES OF GYNECOLOGY AND OBSTETRICS. Bd. 305. H. 5. 2021 S. 1291-1298